Netherton Syndrome Market: Drug Development Pipeline, Key Trends, and Future Opportunities
For decades, netherton syndrome has remained a rare disease without a single disease-modifying option. That is starting to change. A wave of clinical-stage candidates, growing regulatory support, and improved diagnostic awareness are together reshaping the netherton syndrome treatment market, which stood at roughly USD 25 million across the 7MM in 2024 and is projected to grow steadily through...
0 Commenti 0 condivisioni 1K Views 0 Anteprima